{
    "Trade/Device Name(s)": [
        "ACL TOP 970 CL"
    ],
    "Submitter Information": "Instrumentation Laboratory Company",
    "510(k) Number": "K233790",
    "Predicate Device Reference 510(k) Number(s)": [
        "K150877"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JPA"
    ],
    "Summary Letter Date": "December 29, 2023",
    "Summary Letter Received Date": "November 28, 2023",
    "Submission Date": "November 28, 2023",
    "Regulation Number(s)": [
        "21 CFR 864.5425"
    ],
    "Regulation Name(s)": [
        "Multipurpose system for in vitro coagulation studies"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "D-dimer",
        "Factor VIII",
        "Prothrombin Time",
        "Fibrinogen",
        "Heparin"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Sample tubes"
    ],
    "Instrument(s)/Platform(s)": [
        "ACL TOP 970 CL",
        "ACL TOP 550 CTS (Main Module)",
        "Chemiluminescent (CL) Module"
    ],
    "Method(s)/Technology(ies)": [
        "Coagulometric (Turbidimetric) measurement",
        "Chromogenic (Absorbance) measurement",
        "Immunological measurement",
        "Chemiluminescence (CL)"
    ],
    "Methodologies": [
        "Coagulation testing",
        "Fibrinolysis testing"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for ACL TOP 970 CL, a fully automated coagulation analyzer for in vitro assessment of thrombosis and hemostasis.",
    "Indications for Use Summary": "Bench top, fully automated, random access analyzer for in vitro diagnostic use by clinical laboratory professionals for coagulation and/or fibrinolysis testing in the assessment of thrombosis and/or hemostasis.",
    "fda_folder": "Hematology"
}